Offer - Urjas Oil for just ₹ 1
Glizid Total P 7.5 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Diabetes Type 2, Diabetes Type 2, Diabetes. Other than this, Glizid Total P 7.5 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Glizid Total P 7.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Glizid Total P 7.5 Tablet include Constipation, Abdominal Pain, Indigestion. Besides the aforementioned side effects, there are other adverse effects of Glizid Total P 7.5 Tablet as well, which are listed below. Such side effects of Glizid Total P 7.5 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Glizid Total P 7.5 Tablet's effect during pregnancy is Mild and Moderate while nursing. Warnings related to Glizid Total P 7.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease, Diabetic Ketoacidosis must refrain from the use of Glizid Total P 7.5 Tablet since this can cause severe adverse effects. The section on Glizid Total P 7.5 Tablet contraindications lists all such conditions.
Besides this, Glizid Total P 7.5 Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Glizid Total P 7.5 Tablet is safe while driving, and is addiction.
Glizid Total P 7.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Glizid Total P 7.5 Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Glizid Total P has mild side effects when taken during pregnany
Is the use of Glizid Total P 7.5 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Glizid Total P. If you see any side effects, stop taking Glizid Total P immediately and talk to your doctor. Take Glizid Total P again, only after your doctor's advice.
What is the effect of Glizid Total P 7.5 Tablet on the Kidneys?
Glizid Total P is not harmful for kidneys.
What is the effect of Glizid Total P 7.5 Tablet on the Liver?
Glizid Total P is completely safe for the liver.
What is the effect of Glizid Total P 7.5 Tablet on the Heart?
There are no any side effects of Glizid Total P for the heart.
If you are suffering from any of the following diseases, you should not take Glizid Total P 7.5 Tablet unless your doctor advises you to do so -
Is this Glizid Total P 7.5 Tablet habit forming or addictive?
Forming a habit of Glizid Total P 7.5 Tablet has not been reported.
Interaction between Food and Glizid Total P 7.5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Glizid Total P 7.5 Tablet together with food.
Interaction between Alcohol and Glizid Total P 7.5 Tablet
Consuming Glizid Total P 7.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826